Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates

There is a persistent need to look for alternative therapeutic modalities to help control the pandemic of antimicrobial resistance. Assessment of antibacterial and anti-biofilm effects of vitamin C (ascorbic acid) was the aim of the current study. The micro-dilution method determined the minimal inh...

Full description

Bibliographic Details
Main Authors: Wedad M. Abdelraheem, Marwa M. M. Refaie, Rehab Kamal Mohamed Yousef, Aliaa S. Abd El Fatah, Yosra M. Mousa, Rabab Rashwan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.847449/full
_version_ 1828219187267371008
author Wedad M. Abdelraheem
Marwa M. M. Refaie
Rehab Kamal Mohamed Yousef
Aliaa S. Abd El Fatah
Yosra M. Mousa
Rabab Rashwan
author_facet Wedad M. Abdelraheem
Marwa M. M. Refaie
Rehab Kamal Mohamed Yousef
Aliaa S. Abd El Fatah
Yosra M. Mousa
Rabab Rashwan
author_sort Wedad M. Abdelraheem
collection DOAJ
description There is a persistent need to look for alternative therapeutic modalities to help control the pandemic of antimicrobial resistance. Assessment of antibacterial and anti-biofilm effects of vitamin C (ascorbic acid) was the aim of the current study. The micro-dilution method determined the minimal inhibitory concentration (MIC) of ascorbic acid or antibiotics alone and in combinations against Pseudomonas aeruginosa (P. aeruginosa) clinical isolates. The micro-titer plate method monitored the effect of ascorbic acid on the biofilm-producing isolates of P. aeruginosa. The effect of ascorbic acid on the differential expression of different antibiotic-resistant genes and biofilm encoding genes of P. aeruginosa isolates were also tested using real-time polymerase chain reaction (PCR). For in vivo assessment of the antibacterial effects of ascorbic acid alone or combined with an antibiotic, rats were infected with P. aeruginosa clinical isolate followed by different treatment regimens. MICs of ascorbic acid among P. aeruginosa isolates were in the range of 156.2–1,250 μg/ml, while MIC50 and MIC90 were 312.5 and 625 μg/ml, respectively. At sub-inhibitory concentrations (19.5–312.5 μg/ml), ascorbic acid had 100% biofilm inhibitory effect. Furthermore, ascorbic acid-treated bacteria showed downregulation of genes underpinning biofilm formation and antibiotic resistance. In vivo assessment of vitamin C and ceftazidime in rats showed that administration of both at a lower dose for treatment of pseudomonas infection in rats had a synergistic and more powerful effect. Vitamin C shows excellent in vitro results as an antibacterial and anti-biofilm agent. Vitamin C should be routinely prescribed with antibiotics to treat bacterial infections in the clinical setting.
first_indexed 2024-04-12T16:13:22Z
format Article
id doaj.art-13a187fdfb0840dab02e93e9998a5735
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-12T16:13:22Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-13a187fdfb0840dab02e93e9998a57352022-12-22T03:25:50ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2022-05-011310.3389/fmicb.2022.847449847449Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical IsolatesWedad M. Abdelraheem0Marwa M. M. Refaie1Rehab Kamal Mohamed Yousef2Aliaa S. Abd El Fatah3Yosra M. Mousa4Rabab Rashwan5Department of Medical Microbiology and Immunology, Faculty of Medicine, Minia University, Minya, EgyptDepartment of Pharmacology, Faculty of Medicine, Minia University, Minya, EgyptDepartment of Pathology, Faculty of Medicine, Minia University, Minya, EgyptInternal Medicine Department, Faculty of Medicine, Minia University, Minya, EgyptChest Department, Faculty of Medicine, Minia University, Minya, EgyptDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Minia University, Minya, EgyptThere is a persistent need to look for alternative therapeutic modalities to help control the pandemic of antimicrobial resistance. Assessment of antibacterial and anti-biofilm effects of vitamin C (ascorbic acid) was the aim of the current study. The micro-dilution method determined the minimal inhibitory concentration (MIC) of ascorbic acid or antibiotics alone and in combinations against Pseudomonas aeruginosa (P. aeruginosa) clinical isolates. The micro-titer plate method monitored the effect of ascorbic acid on the biofilm-producing isolates of P. aeruginosa. The effect of ascorbic acid on the differential expression of different antibiotic-resistant genes and biofilm encoding genes of P. aeruginosa isolates were also tested using real-time polymerase chain reaction (PCR). For in vivo assessment of the antibacterial effects of ascorbic acid alone or combined with an antibiotic, rats were infected with P. aeruginosa clinical isolate followed by different treatment regimens. MICs of ascorbic acid among P. aeruginosa isolates were in the range of 156.2–1,250 μg/ml, while MIC50 and MIC90 were 312.5 and 625 μg/ml, respectively. At sub-inhibitory concentrations (19.5–312.5 μg/ml), ascorbic acid had 100% biofilm inhibitory effect. Furthermore, ascorbic acid-treated bacteria showed downregulation of genes underpinning biofilm formation and antibiotic resistance. In vivo assessment of vitamin C and ceftazidime in rats showed that administration of both at a lower dose for treatment of pseudomonas infection in rats had a synergistic and more powerful effect. Vitamin C shows excellent in vitro results as an antibacterial and anti-biofilm agent. Vitamin C should be routinely prescribed with antibiotics to treat bacterial infections in the clinical setting.https://www.frontiersin.org/articles/10.3389/fmicb.2022.847449/fullantimicrobial and anti-biofilm effects of vitamin Canti-biofilm strategiessynergismMDRbiofilm former P. aeruginosa strains
spellingShingle Wedad M. Abdelraheem
Marwa M. M. Refaie
Rehab Kamal Mohamed Yousef
Aliaa S. Abd El Fatah
Yosra M. Mousa
Rabab Rashwan
Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
Frontiers in Microbiology
antimicrobial and anti-biofilm effects of vitamin C
anti-biofilm strategies
synergism
MDR
biofilm former P. aeruginosa strains
title Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
title_full Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
title_fullStr Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
title_full_unstemmed Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
title_short Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
title_sort assessment of antibacterial and anti biofilm effects of vitamin c against pseudomonas aeruginosa clinical isolates
topic antimicrobial and anti-biofilm effects of vitamin C
anti-biofilm strategies
synergism
MDR
biofilm former P. aeruginosa strains
url https://www.frontiersin.org/articles/10.3389/fmicb.2022.847449/full
work_keys_str_mv AT wedadmabdelraheem assessmentofantibacterialandantibiofilmeffectsofvitamincagainstpseudomonasaeruginosaclinicalisolates
AT marwammrefaie assessmentofantibacterialandantibiofilmeffectsofvitamincagainstpseudomonasaeruginosaclinicalisolates
AT rehabkamalmohamedyousef assessmentofantibacterialandantibiofilmeffectsofvitamincagainstpseudomonasaeruginosaclinicalisolates
AT aliaasabdelfatah assessmentofantibacterialandantibiofilmeffectsofvitamincagainstpseudomonasaeruginosaclinicalisolates
AT yosrammousa assessmentofantibacterialandantibiofilmeffectsofvitamincagainstpseudomonasaeruginosaclinicalisolates
AT rababrashwan assessmentofantibacterialandantibiofilmeffectsofvitamincagainstpseudomonasaeruginosaclinicalisolates